Pharmaceutical Market News and Analysis from a Global Perspective

Gloved hands preparing a syringe with a vial in a lab setting.

Biotech and Pharma Market Update: Q1 2025 in Review

The healthcare sector faced a whirlwind of challenges and opportunities in Q1, from major acquisitions to regulatory uncertainties. What will Q2 bring for biotech and pharma?

Life Science Investing News

Investing News NetworkYour trusted source for investing success

Pharmaceutical Investing: World

Coverage of the pharma market for global investors, including news, analysis forecasts, and stock updates.

Biotech and Pharma Market Update: Q1 2025 in Review

Trump Signs Sweeping Order to Slash Drug Prices, Pressure Pharma Giants

5 Biggest Pharmaceutical ETFs in 2025

Top 5 Small-cap Pharma Stocks in 2025

Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

What is In-Licensing?

Amgen, Merck and Pfizer Release Latest Quarterly Earnings, Share 2025 Plans

Invion Limited

Cardiol Therapeutics

AbbVie Inc.

Sirona Biochem Eyes 2025 Launch of New Anti-aging Product

"Wrap-around Care" Model Helps Address Gaps in Mental Healthcare

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

Johnson & Johnson to Expand Neuroscience Portfolio with US$14.6 Billion Acquisition

Pharma Market Forecast: Top Trends for Pharma in 2025

5 Best-performing Canadian Pharma Stocks (Updated January 2025)

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial

Appendix 4C and Quarterly Activities Report - March 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Invion: Revolutionizing Photodynamic Therapy (PDT) for Cancer, Infectious Diseases

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

BCAL Diagnostics Launches BREASTEST plus - Generating First Revenues

Successful Completion of Placement to Accelerate Clinical Programs

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Invion Doses First Patient in Phase I/II Non-Melanoma Skin Cancer Trial

Harris vs. Trump: The 2024 US Election, Drug Prices and Healthcare

How Big Tech is Helping Leverage Big Data in Healthcare

Pharma Market Forecast: Top Trends That Will Affect Pharma in 2024

Latest pharmaceutical News